Dyania Health

United States
Jersey City, New Jersey, United States

Company profile

Dyania Health company profile

Dyania’s mission is to deploy their medically specialized and proprietary Synapsis AI to automate manual chart review, one of the most inefficient and time-consuming processes in modern healthcare, thereby empowering clinicians to deliver optimal care, precisely when patients need it. Dyania’s system is being used at large healthcare systems to unlock enterprise-wide clinical trial pre-screening, run automated chart review for observational studies, and automate complex registry reporting, dramatically reducing manual workloads and ensuring more accurate and timely patient care.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2019-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
3
Total equity funding
$17.3M
Last funding
Series A / $10M / 2024-10-24
Last equity funding
Series A / $10M
Investors
12
Lead investors
3
Founders
2
Articles
12

Founders and investors

Founders

Dimitrios IliopoulosEirini Schlosser

Lead investors

HealthX VenturesInnospark VenturesStage Venture Partners

Investors

Big Pi VenturesGenesis VenturesInnospark VenturesOutsiders FundTau Ventures